Linezolid is indicated in adults and children for the treatment of infections caused by susceptible Gram-positive bacteria, including nosocomial pneumonia, community-acquired pneumonia, skin and skin structure infections, and vancomycin-resistant Enterococcus faecium infections.
Myelosuppression have been reported. MAO inhibitor properties. Should be take with caution in Patients with uncontrolled hypertension, pheochromocytoma, carcinoid syndrome or untreated hyperthyroidism, avoid use with serotonegic agents.